Skip to content

Trima Accel® 81001

by Terumo BCT, Inc.

Trima Accel 81001 is an apheresis system (FDA Class II; FDA product code GKT, Separator, automated, blood cell, diagnostic) made by Terumo BCT, Inc., listed under FDA premarket submission BK970023 and listed in FDA GUDID since 15 Sep 2016 (UDI-DI 05020583810013), active as of 8 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 8 Nov 2026

Documents

510(k) BK970023

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number05020583810013 UDI-DI Date15 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k) from GUDID NumberBK970023 Date—StatusActive

Official records

From the FDA record

Device description
Automated Blood Collection System
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 8 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA premarket submission BK970023 Active
  • FDA GUDID UDI-DI 05020583810013 listed 15 Sep 2016 Listed

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Trima Accel®
Generic name
Apheresis system
Model / reference
81001
Primary DI / UDI-DI
05020583810013
FDA product code
GKT
GMDN term
Apheresis system
Device class
Class II
Regulation number
864.9245
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Apheresis system.

Other devices from Terumo BCT, Inc.

See all devices from Terumo BCT, Inc. →

Properties

  • Prescription use
  • Serial number
Other properties (13, all answered No)